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Background: Diseases such as tuberculosis (TB) have always had a large impact on human health. Bacillus
Calmette-Guérin (BCG) is used as a surrogate for TB during the development of anti-TB drugs. Nanoparticles (NPs)
have attracted great interest in drug development. The purpose of this study was to examine the potential of NPs
as anti-TB compounds by studying the interacting mechanisms between NPs and bacteria.
Results: We investigated effects of gold and silver NPs on BCG and Escherichia coli. Experimentally, particle size and
shape were characterized using transmission electron microscopy (TEM). Different concentrations of NPs were
applied in bacterial culture. The growth of E. coli was monitored through colony forming units (CFU). The
mechanism of interaction between NPs and bacteria was analyzed through bacterial thin sections followed by TEM
and scanning electron microscopy. Antibacterial effects on BCG were observed by recording fluorescent protein
expression levels.
Conclusions: The results suggest NPs have potential applications as anti-TB compounds. The antibacterial effects
and mechanism of action for NPs were dependent upon composition and surface modifications.
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Diseases such as tuberculosis (TB) have always had a
large impact on human health. According to a recent
World Health Organization (WHO) report, there were
an estimated 11.1 million prevalent cases and 9.4 million
incident cases of TB in 2008. There are 1.3 million TB
related deaths each year [1]. As a widely used TB vac-
cine, bacillus Calmette-Guérin (BCG) has been prepared
from a strain of attenuated Mycobacterium bovis, which
causes bovine tuberculosis. The virulence of BCG was
lost after being cultured in potato medium for decades.
In biosafety level 2 labs, it has been used as a surrogate
for TB during the development of anti-TB drugs. Com-
bination drug therapies are normally used against TB,* Correspondence: hliang@tamu.edu
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reproduction in any medium, provided the orsince monotherapy fails to clear infections and leads to
rapid development of resistance. There are drawbacks in
current therapies, including drug-induced disease and
the increasing prevalence of multiple-drug-resistant tu-
berculosis (MDR-TB). Nanoparticles (NPs) have attracted
great interest in their development as potential antibac-
terial drugs [2,3]. It has been reported that biophysical
interactions occur between NPs and bacteria including
biosorption, NPs breakdown or aggregation, and cellular
uptake, with effects including membrane damage and
toxicity [4,5]. The mechanisms of NPs inhibiting bacter-
ial growth remain less well understood. It has been
reported that the size and surface modifications of NPs
could affect their antibacterial levels [5,6]. Comprehen-
sive understanding of antibacterial mechanisms is needed
to improve the effectiveness of NPs in disease treatment.
Colloidal silver has been used as an antibacterial agent
since ancient Greece [7]. Unlike antibiotic drugs, bacteria
cannot easily develop resistance because silver targets
multiple components in the bacterial cell. As a result,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tal resin components [9]. It is also reported that the
mechanism behind its antibacterial activity is by weaken-
ing DNA replication and inactivating proteins [10]. On
the contrary, gold has low toxicity to biological systems,
whether bacteria, animal, or human, due to its elemental
properties [11].
To date, comprehensive studies on nanoparticles have
rarely been carried out in bacteria. To understand their
interactions, we investigated the antibacterial effects of
NPs with different compositions and surface modifica-
tions. Model bacteria Escherichia coli were tested with
different NPs. Gold and silver NPs were chosen to have
similar sizes and shapes. The growth of E. coli was evalu-
ated by colony forming units (CFU). In order to investi-
gate the mechanisms involved, transmission electron
microscopy (TEM) and field emission scanning electron
microscopy (FE-SEM) analyses were carried out. This
mechanistic study provided information on how NPs
interact with bacteria dynamically. The level of fluores-
cence expression was found to correlate with the num-
bers of viable BCG cells, as a result, we were able to
monitor antibacterial activity of NPs on BCG cells. In
terms of anti-TB drug development, this study suggests
that NPs may represent useful candidates for
therapeutics.
Results
Preparation and characterization of nanoparticles
TEM micrographs of citrate Au and Ag NPs were
obtained with NP solutions after centrifugation and re-
suspension in DI water, and TEM micrographs of poly-
allylamine hydrochloride (PAH) Au NPs were acquired
with NPs in solution as they were made. In the case of
Au NPs prepared in citrate, spherical NPs with 20−30
nm diameter were observed (Figure 1A), gold nanoparti-
cles were well dispersed after rounds of centrifugation
and re-suspension. PAH stabilized Au NPs were spher-
ical and approximately 22 nm in diameter (Figure 1B),
and the presence of polyelectrolyte forced the formation
of monodispersed gold nanoparticle ‘aggregates’. Ag NPs
were produced in Triton X-100 (TX-100) solution and
reached an average diameter of 30 nm (Figure 1C). All
NPs showed consistent spherical morphology and nar-
row size distribution between 20 and 30 nm. This
consistency helped minimize the shape and size differ-
ences that might result in different antibacterial effects.
Figure 1D shows thin section of E. coli grown in LB li-
quid medium. Bacterial cells exhibited well-defined cellu-
lar contents and were normal in size with intact
intracellular structures.
Nanoparticles in solution were added to fresh LB
medium for four hours to examine the level of aggre-
gation, as shown in Figure 2, and the finalconcentration of NPs were chosen to be 10 μg/ml.
The level of aggregation of citrate Au NPs was higher
in LB medium (Figure 2A) as compared to in DI
water (Figure 1A). This might have been expected,
since the medium is full of nutrients as well as free
ions both of which could exchange with citrate on the
nanoparticles surface and cause aggregation. The ex-
change process is less likely to occur when high mo-
lecular weight molecules, such as polyelectrolyte
(PAH), were used for surface modifications. The result
is the level of aggregation stayed the same after add-
ing LB (Figure 2B). Ag NPs display aggregation after
suspending them in LB medium (Figure 2C).
Antibacterial effect of NPs on E. coli
NPs were added to LB medium to reach predesigned
concentrations. E. coli was exposed to 0.1, 1, 5,
10 μg/ml citrate or PAH Au NPs and 1, 10 μg/ml Ag
NPs. At selected times, 10 μl of medium was
sampled, diluted and then cultured on LB ager plates.
OD600 was also monitored over time. Considering the
OD600 value of NPs in LB medium as background, it
was expected that we could estimate bacterial num-
bers by subtracting background from each measure-
ment. It was found that there was no OD600 additive
relationship between NPs and bacteria (data not
shown). After NPs were added to the bacterial cul-
ture, bacterial cells attracted NPs. Thus, the OD600
reading that would normally be generated by this por-
tion of NPs was absent. As a result, CFU is likely to
be the only accurate method to determine bacterial
numbers with little influence from the NPs. CFU data
were converted to bacterial numbers per ml as shown
in Figure 3. The presence of NPs reduced the bacter-
ial numbers during the exponential phase. High con-
centrations of citrate Au NPs have less of an
inhibitory effect on bacterial growth as compared to
low concentrations (Figure 3A). At 10 μg/ml, citrate
Au NPs appeared to form aggregates which contain
multiple mono-dispersed nanoparticles, and there is
no opportunity for NPs inside ‘aggregates’ to interact
with cells (Figure 2A). This also left fewer non-aggre-
gated NPs which can be easily absorbed by bacteria.
Hence, bacterial growth was only slightly inhibited at
high citrate Au NPs concentrations. In contrast, E.
coli growth was significantly inhibited by citrated Au
NPs at 0.1, 1, 5 μg/ml. This observation could be
explained by the fact that smaller aggregates exist at
lower NPs concentrations. In such, more NPs can
interact with bacterial cells and cause further damage.
Figure 3B presents a dose-dependent relationship be-
tween PAH Au NPs and bacteria inhibition. It sug-
gests that bacterial growth was less inhibited when
0.1 and 1 μg/ml PAH Au NPs were present, so there
Figure 1 TEM images of NPs. Transmission electron micrographs of (A) citrate Au NPs after centrifugation and re-suspension in water, (B) PAH
Au NPs as prepared, (C) Ag NPs after centrifugation and re-suspension in water, and (D) E. coli in the absence of NPs.
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controls. E. coli was largely inhibited by 5 and 10 μg/
ml of PAH Au NPs. The effects of PAH toxicity on
bacterial killing was evaluated by determining the
minimal inhibitory concentration (MIC) for PAH. The
initial concentration of PAH for making PAH Au NPs
was 1000 mg/L, and most of PAH was removed after
NPs formation by centrifugation and re-suspension in
water. As shown in Figure 3D, the only concentrationFigure 2 NPs solution was added to LB medium for four hours to exa
10 μg/ml PAH Au NPs in LB medium. (C) 10 μg/ml Ag NPs in LB medium. Sof PAH that display bacterial inhibitory effects is
2000 mg/L and lower concentrations showed no in-
hibitory effect. Hence, the antibacterial effect of PAH
Au NPs is not due to concentrations of PAH that
could remain after processing. At 260 min, hygromy-
cin treated E. coli started to replicate while 5 and
10 μg/ml PAH Au NP treated groups still displayed
no growth. This suggests that there are stronger anti-
bacterial effects at these concentrations as comparedmine the aggregation. (A) 10 μg/ml citrate Au NPs in LB medium. (B)
cale bars represent 50 nm.
Figure 3 The antibacterial effects of different NPs on E. coli and the MIC of PAH. In the antibacterial test of NPs, bacterial cell cultures were
set up at an initial optical density (OD) of 0.003 from an overnight culture. NPs solution was added into cell culture medium to reach predesigned
concentrations. E. coli was exposed to 0.1, 1, 5, 10 μg/ml citrate and PAH Au NPs (A and B), and to 1, 10 μg/ml Ag NPs (C). 20 μg/ml hygromycin
(Hyg) was used as a positive control and E. coli was used as a negative control. Experiment was repeated three times and the results are shown in
mean ± SD. (D) The MIC of PAH against E. coli. Significant differences were observed on for the 2000 μg/ml PAH experimental group and the
control group. *p< 0.05.
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ities were observed at all Ag NP concentrations
(Figure 3C).
Electron microscopic analysis
Nanopaticle treated E. coli was thin sectioned for TEM
imaging in order to study the mechanisms of the anti-
bacterial interactions. The following concentrations were
selected because they display strong antibacterial effects:
2 μg/ml citrate Au NPs, 5 μg/ml PAH Au NPs and
20 μg/ml Ag NPs. Samples were withdrawn and fixed at
3, 6, and 9 hours. These points were picked since the
interaction is more obvious. Seen from TEM micro-
graphs, NPs are rarely found within E. coli cells after 3
hours of incubation with citrate Au NPs (Figure 4A,
arrow indicates Au NPs aggregates). Most of the NPs are
either free in the medium or aggregated between bac-
teria. Bacterial cell walls started to retain some NPs at 6
hours (arrows in Figure 4B). Figure 4C demonstrates an
increased number of NPs inside bacterial cells after 9hours (arrows in Figure 4C). The NP complexes inside
bacterial cells in Figure 4D and 4E were measured to be
100 nm in diameter, which is equivalent to about 50 in-
dividual NPs and their morphology is quite different
from more dispersed ‘aggregates’ in Figure 2A. It is easy
to distinguish a single NP within the 100 nm complex at
6 hours (inset in Figure 4D). However, given more time,
the outlines of individual NP became blurry within these
complexes, which suggests that single NPs physically
merged with each other and ‘aggregates’ turned into lar-
ger particles (9 h; inset in Figure 4E). PAH Au NPs
showed different antibacterial activity when they were
applied in E. coli culture, cell lysis was observed at 3 h,
6 h, and 9 h (Figure 4F−4I). Au NPs were trapped within
what appeared to be released cytoplasm and no free NPs
were found in the medium (arrows in Figure 4F and 4G).
Release of the cytoplasm left hollow and disfigured cell
walls (arrows in Figure 4H and 4I). TEM micrographs of
Ag NPs treated E. coli at different time points are shown
in Figure 4J−4N. Arrows in Figure 4J indicate Ag
Figure 4 TEM images of E. coli with NPs at different time points. (A−E) E. coli with citrate Au NPs at (A) 3 h, (B) and (D) 6 h, (C) and (E) 9 h.
(Inset) Magnified 100 nm complex pointed by arrows. (F−I) E. coli with PAH Au NPs at (F) 3 h, (G) 6 h, (H) and (I) 9 h.(J−N) E. coli with Ag NPs at (J)
3 h, (K) and (M) 6 h, (L) and (N) 9 h. Arrows point to NPs (A−G, J−N) and hollow cells (H and I).
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Ag NPs complexes inside of cells. As seen in Figure 4M
and 4N, NPs maintain their original size and spherical
shape. A large portion of the Ag NPs was trapped within
the cell walls (Figure 4L−4N).
FE-SEM was used to examine the interactions of NPs
with bacteria in more detail and the results are shown in
Figure 5. E. coli was fixed after 30 min of incubation with
citrate Au NPs. In secondary electron mode, Au NPs
were found aggregated (Figure 5A), which is in accord-
ance with the TEM result in Figure 3A. Besides aggre-
gated Au NPs, some Au NPs were found dispersed
among cells, as shown through back-scattered imaging
(Figure 5B).
Antibacterial effect of NPs on BCG
The relationship between viable cell numbers and fluores-
cence was shown in Figure 6A. The level of fluorescence
was correlated with bacterial numbers, as confirmed byCFU (R2 = 0.994). All NPs were found to have no emission
at 554 nm excitation. Hence, there is no interference of
NPs with fluorescence emission. After 5 days of BCG/NPs
co-culture, fluorescence was measured and the results are
shown in Figure 6B−6D. BCG fluorescence was inhibited
by citrate Au NPs at all concentrations tested (Figure 6B).
The inhibitory effect of citrate Au NPs was more obvious
at 0.1 and 1 μg/ml which is in accordance with E. coli in-
hibition. Low fluorescence levels were found when PAH
Au NPs were at high concentrations (Figure 6C). This
dose-dependent relationship for PAH Au NPs was
observed for both E. coli and BCG. When BCG was trea-
ted with 1, 5, 10 μg/ml of Ag NPs, it displayed similar
fluorescence to that of the hygromycin treated group
(Figure 6D).
Discussion
In the present research, we evaluated the antibacterial activ-
ity of nanoparticles. These particles differ in combinations
Figure 5 FE-SEM of E. coli in the presence of citrate Au NPs. (A) secondary electron image, (B) backscattered electron image. Arrows point to
Au NPs
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size and shape remain the same. The surface charge and
chemical properties of NPs are determined by capping
agents, which play an important role during NPs and bac-
terial interactions. For the same type, NPs stabilized with a
weakly bound capping agent (citrate) tend to aggregate
more as compared to those with a strongly bound capping
agent (PAH), as shown in Figure 1A and 1B. The increased
aggregation means reduced the surface area that wouldFigure 6 Fluorescence expression of BCG. Tdtomato fluorescence protei
viable bacteria cells under treatment with NPs. (A) Correlation of the numb
day zero, fluorescence of BCG was 701.7 ± 61.6. After five days incubation w
(C) Fluorescence of BCG with 1, 5, 10, 20 μg/ml PAH Au NPs. (D) Fluorescen
repeated three times and the results are shown in mean ± SD. Comparison
effects. *p< 0.05: significant difference from NP-free BCG control.reduce the interactions between NP and bacteria resulting
bacterial inhibitory interactions. The evidence is seen in
non-dose dependent relations (Figure 3A). Citrate has been
used as a carbon source to differentiate E. coli from other
species since the bacteria is incapable of transferring citrate
through its membrane [12,13]. The formation of aggregates
is most likely caused by citrate reduction within the capping
agent [14]. It is believed that ion/molecule in medium ex-
change with citrate resulted in this reduction and thusn expressed by bacillus Calmette-Guérin (BCG) allows fast detection of
er of BCG and fluorescence level was determined by CFU, R2 = 0.994. At
ith NPs, (B) Fluorescence of BCG with 0.1, 1, 5, 10 μg/ml citrate Au NPs.
ce of BCG with 1, 5, 10, 20 μg/ml Ag NPs. The experiment was
was made with NP-free BCG control to determine the antibacterial
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erogeneous and some Au NPs remained the original 20 nm
in size, once they have entered a cell, Au NP aggregation
turned into complex structures where single NP physically
connected with each other while citrate ions were kept out-
side the cell. These are seen in Figure 4D and 4E. Bacteria
appeared to take up single nanoparticles and rearrange
them inside cytoplasm, as shown in Figure 4C and 4E, the
particles within cells showed a broad size range. The pro-
posed mechanism is described in Figure 7A. Due to the
increased size and resistance to cutting resulted of NP com-
plexity, dislocation appeared when the sectioning blade was
in contact with the NPs during sample sectioning. Holes
observed in the sections represent the positions where NPs
were located prior to sectioning (Figure 4C).
Our results suggest a different antibacterial mechanism
for PAH Au NPs from citrate Au NPs. A previous report
shows that PAH Au NPs self-assemble into 4−5 micron
long chains, which is an indication of strong interactions
between NPs and PAH [15]. As a result, PAH NPs did
not further aggregate in culture media and dose-
dependent relations seen in Figure 3B. Furthermore,
PAH organized chain-like aggregates were disturbed
once they entered the cell, and more scattered Au NPs
were found within pools of released cytoplasm (Fig-
ure 4F−4I). The hypothesis for this mechanism is shownFigure 7 Schematic representation of the interactions between NPs a
aggregations of Au NPs complexes. (B) PAH facilitates Au NPs uptake into b
walls.in Figure 7B. PAH facilitated the delivery of a large num-
ber of Au NPs that strongly bond to PAH on the bacter-
ial cell surface. Bacteria cell wall tends to attract positive
charged PAH due to the total charge of cell wall being
negative [16]. As a result, cell walls encounter high stress
as they accumulate PAH and Au NPs. Since the MIC of
PAH is well above the concentrations likely to be present
in the NPs, as shown in Figure 3D, the PAH is not re-
sponsible for the toxic effects of NPs for bacteria. Once
Au NPs penetrate the cell wall and enter the cytoplasm,
PAH is more likely to have direct contact with the cell
membrane through damaged cell wall. Then, PAH could
play a role in accelerating cell wall breakdown and cyto-
plasm release. It has been reported that cationic coated
Au NPs are more toxic than anionic coated ones [16],
and this supports the concept that PAH Au NPs caused
immediate cell lysis while citrate Au NPs did not. Fur-
thermore, the mechanism of interaction between Ag NPs
and E. coli is described in Figure 7C. The high antibac-
terial activity resulted from the nature of the silver elem-
ent, and possibly the neutral TX-100, which could
participate in the interaction. Based on FE-SEM images,
several Au NPs were very close to each other tending to
aggregate (arrows in Figure 5B). NPs tend to bind to the
long end of the cell, it is likely that the ends providing a
better site for attachment.nd bacterial cells. (A) Bacterial cells take up single citrate Au NPs or
acterial cells followed by lysis. (C) Most of Ag NPs were trapped in cell
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reduced BCG’s fluorescence. Since the level of fluorescence
correlates with numbers of viable BCG as tested by CFU
(Figure 6A), this assay provides a fast way to monitor the
growth of slow-glowing mycobacteria. From the reduction
of fluorescence, we can conclude that BCG growth is
inhibited by NPs, which could be ideal candidates for drug
development.
Conclusions
In conclusion, we have demonstrated that gold and silver
nanoparticles display excellent antibacterial potential for
the Gram negative bacteria E. coli and the Gram positive
bacteria BCG. These NPs display their best performance
when aggregation is not observed at high levels. By chan-
ging surface modifications agents, gold NPs with the
same shape and size exhibited different inhibitory effects.
Our mechanistic analyses indicated that PAH capped
gold NPs caused cell lysis, while citrate capped gold NPs
did not. Strong antibacterial activities were observed for
silver NPs due to their inherent elemental properties. In
terms of anti-TB drug development, this study suggests
that NPs may represent useful candidates, but will re-
quire significant development to ensure optimal bacteri-
cidal activity and low host toxicity.
Methods
Nanoparticles (NPs)
Citrate stabilized gold (Au) NPs were prepared following
previously reported methods [17]. Citrate ions produce
negative charges on the surface of nanoparticles. By con-
trolling citrate and hydrogen tetrachloroaurate tri-hydrate
(HAuCl4) concentrations, 20−30 nm diameter Au NPs
were synthesized. Poly-allylamine hydrochloride (PAH)
stabilized Au NPs with 22 nm mean size were synthesized
in an aqueous solution of HAuCl4 and PAH and in the
presence of gold seed particles [15]. A positive charge was
demonstrated on Au NPs’ surface because of the presence
of PAH. Silver (Ag) NPs were produced by photoirradiat-
ing AgNO3 in Triton X-100 (TX-100) solution for 60 min,
the average size was around 30 nm [18]. Citrate Au NPs
and Ag NPs solutions were centrifuged at 8000 rpm for
15 min to remove extra citrate and TX-100. The precipi-
tated NPs were suspended in DI water. This process was
repeated 3−4 times. PAH Au NPs were used immediately
after they were made, since precipitated NPs were unable
to dissolve in water.
Bacterial Growth and Exposure
pBlueScriptKSII + plasmid (Agilent Technologies, Santa
Clara, CA) was transformed into Escherichia coliDH5α
(Invitrogen, Carlsbad, CA). E. coli was grown in liquid
Luria-Bertani (LB) medium at 37°C and 250 rpm. Bacillus
Calmette-Guérin (Pasteur) cultures expressing tdTomatofluorescent protein were grown in M-OADC-TW broth
with Middlebrook (M) 7 H9 broth (Difco) supplemented
with 10% (v/v) oleic acid albumin dextrose complex, 0.5%
(v/v) glycerol, and 0.05% (v/v) Tween 80. Medium was
supplemented with 25 μg/ml kanamycin. NPs in solution
were added into bacteria cultures to reach specific
concentrations.
Characterization
NPs samples for TEM imaging were prepared by slow
evaporation of freshly made NPs in solution on a car-
bon-coated copper grid at room temperature. Bacterial
samples were fixed in 2% (v/v) glutaraldehyde for 0.5 h
at 37°C by adding fixative into culture medium. The fol-
lowing process was performed with cold microwave
technology in the BioWave. The microwave was set for a
6 minute cycle (2 min power on, 2 min power off, 2 min
power on) at 200 W for primary fixation. Alternating
vacuum cycles of 30 seconds were used during 6 minutes
of fixation. The microwave temperature was set at 20°C
for all steps. Bacteria were spun down and washed 3
times with 0.1 M HEPES for 1 min at 200 W with con-
sistent vacuum. Subsequently, 1% (v/v) osmium tetroxide
in HEPES buffer was used for overnight post fixation.
Samples were microwaved for 6 min at 100 W at the
same power and vacuum cycles as used in primary fix-
ation. Methyl alcohol was used for dehydration in 10%
(v/v) steps from 10% to 100%. Microwave was set at
100 W with 1 min per step. Quetol 651 epoxy resin was
used for specimen embedding. Thin sections were picked
up on 200 mesh copper grids and imaged with a JEOL
1200EX TEM with 100 keV acceleration voltage [19]. FE-
SEM sample preparation followed the same fixation and
dehydration procedure described above. Images were
taken on an FEI Quanta 600 FE-SEM at an acceleration
voltage of 10 keV. ImageJ software was used for measur-
ing nanoparticle size distribution.
Antibacterial test
E. coli cells were grown in LB liquid medium at 37°C for
12 hours before they were diluted in fresh LB liquid
medium to reach OD600 = 0.003 (optical density). Gradient
concentrations of NPs were then added to the culture
medium. Bacteria/NP mixed cultures were put into a 37°C
incubator. At different time points of 80, 120, 160, 200,
and 260 min the medium was withdrawn from each sam-
ple. Dilutions were then made and cultured on LB agar
plates. Plates were incubated overnight at 37°C and CFU
was determined. NP-free E. coli was used as a negative
control and 20 μg/ml hygromycin was used as a positive
control for bactericidal activity. The toxicity of PAH was
tested by determining its minimum inhibitory concentra-
tion (MIC). Overnight cultured E. coli suspensions were
adjusted in fresh LB liquid medium to reach an OD600 =
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LB media. After mixing 50 μL E. coli dilution and 50 μL
PAH solution, 10 μL of the sample was immediately drawn
out and a series of dilutions made. Samples were plated on
LB agar plates, and colonies were counted the next day
[20].
Fluorescence Spectrophotometer
BCG::tdTomato with OD600 = 0.05 was cultured in 96
well plates with different NPs at various concentrations.
Five days after mixing, fluorescence was measured using
a Perkin Elmer Envision spectrophotometer with an exci-
tation wavelength of 554 nm and emission wavelength of
581 nm. Wells with NP-free BCG::tdTomato were used
as negative controls, and the wells with 20 μg/ml hygro-
mycin in NP-free 7 H9 medium were used as positive
controls for comparison. The t test (student version) was
used to determine the significance of results.
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